Eva Riveira Muñoz
Eva Riveira Muñoz (b. 1977) obtained a degree in Biology from the University of Santiago de Compostela (USC). She then moved to Brussels (Belgium) to pursue a PhD degree, which she obtained from the Université Catholique de Louvain in 2007. Returning to Spain, she spent three years as a post-doc at the Centre for Genomic Regulation in Barcelona. In 2012 she moved to IrsiCaixa, where she is now working as a post-doc at the Virus-Host Interactions group, led by Ester Ballana.
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.
A protein synthesis routes.
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.